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Objectives: Changes in poisoning trends may affect both complications and outcomes in patients with acute
poisoning. This study reports the treatments given and the frequency of complications, also related to treatment,
mortality and sequelae related to various toxic agents.
Methods: All acute poisonings in adults (≥16 years) admitted to the five hospitals in Oslo were included
consecutively during one year (2008 to 2009) in an observational cross-sectional multicenter study. A standardized
form was completed by the treating physician, which covered the study aims.
Results: There were 1065 admissions in 912 patients. The median length of hospital stay was one day, and 49%
were observed in an intensive care unit (ICU). Active treatment was given to 83%, and consisted of supportive
therapy (70%), antidote(s) (38%), activated charcoal (16%) and gastric lavage (9%). The most commonly used
antidotes were flumazenil (19%), naloxone (17%) and N-acetylcysteine (11%). The rate of treatment-related
complications was 2.4% (21/884). Neither flumazenil, naloxone, nor the combination, was associated with
convulsions or other complications. Among those receiving N-acetylcysteine, 5% (6/120) developed allergic
reactions, one of which mandated discontinuation of treatment. Nineteen percent presented in a coma.
Complications developed in 30%, compared with 18% in a 2003 study, mainly respiratory depression (12%),
prolonged QTc interval (6%) and hypotension (5%). Eight patients died (0.8%) and five (0.5%) survived with
permanent sequelae, mainly anoxic brain damage.
Discussion: Few patients stayed more than two days. The use of the ICU was liberal, considering that only one out
of five presented in a coma. Antidotes were frequently given diagnostically. Although N-acetylcysteine induced
allergic reactions, most were mild and treatment discontinuation was only necessary once. The frequency of
complications had almost doubled in five years, although the poisoning pattern was largely unchanged. However,
few patients developed permanent sequelae.
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Acute poisoning contributes to a substantial number of
hospital admissions. In the UK, acute poisoning contrib-
uted 15–20% of the workload in medical departments in
1999 [1]. Alterations in the poisoning pattern affect clin-
ical features, complications and outcomes, making* Correspondence: k.e.hovda@medisin.uio.no
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reproduction in any medium, provided the orregular studies mandatory. Similar clinical studies were
performed throughout Oslo during 1980 and 2003 [2-5].
In 2003, the incidence was 2.0 per 1000 inhabitants and
the outcomes were good, with both low inhospital mor-
tality and sequelae [3].
In 2003, one-quarter of the patients presented in a
coma and one-fifth developed complications. Since 2003,
poisoning by opioids has increased in Oslo (Lund C,
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poisonings in Oslo: Epidemiology, intention and follow-
up, submitted). Diagnostic use of naloxone and flumaze-
nil is common in Oslo, and this use doubled from 1980
to 2003 [3,5]. As there is a risk of causing unnecessary
complications, liberal diagnostic use of flumazenil has
been deemed controversial [6]. The 2003 study reported
a sixfold increased risk of convulsions in patients receiv-
ing both flumazenil and naloxone, but none if they are
given alone [3]. In that study, however, the time of anti-
dote administration was not recorded in relation to the
onset of complications. As such, they could not be dis-
tinguished from complications caused by the poisoning
or cerebral hypoxia itself.
For most acute poisonings, treatment is symptomatic,
as there is seldom time to wait for a laboratory diagno-
sis. The poisoned patients presenting in a coma often re-
quire urgent diagnosis and management [7], and
knowledge of the most common causes is therefore im-
portant for clinicians. Local epidemics of special types of
poisoning may also impose diagnostic challenges [8].
Data on current treatment practice and the rate of
treatment-related complications may reveal important
targets for improvement. Furthermore, the rate of both
diagnostic uses of flumazenil and naloxone, as well as
related complications may have implications, in favor of
discontinuation or augmentation of current practice.
Knowledge of the toxic substances related to poor out-
comes is also important for prevention strategies.
The present study objectives were to study (1) the
treatment given and (2) the frequency of complications,
also related to treatment. Further objectives were (3) to
study the mortality and sequelae and (4) to compare
findings with previous studies in 1980 and 2003.Material and methods
Study design
This study was part of a larger one-year observational
cross-sectional multicenter study conducted at the out-
patient Emergency Medical Agency (EMA, “Oslo Lege-
vakt”), the Institute of Forensic Medicine and the five
hospitals in Oslo treating poisoned patients. This paper
presents data on their clinical course and treatment in
hospitals. Data on the poisoning patterns in hospitals,
deaths outside hospitals and on outpatient treatment of
acute poisoning are presented separately. For compara-
tive reasons, this study was designed similarly to the
studies conducted in 1980 and 2003 [2,5]. In July 2008,
there were 466 423 inhabitants ≥16 years in Oslo, the
capital of Norway. As Akershus University Hospital
treats patients from two municipalities, patients with
residency outside Oslo treated in this hospital were
excluded.Selection of participants
All adults (≥16 years) exposed to a substance in toxic
amounts and leading to hospital admission were
included consecutively from April 15th 2008 to April
14th 2009. Chronic poisonings were not included. One
fatal case of subacute methotrexate poisoning (medica-
tion error) and one fatal case of acute renal failure caus-
ing subacute metformin poisoning were excluded. In
cases where the poisoning was an additional diagnosis,
the poisoning had to warrant admission itself. In cases
where ethanol and trauma were codiagnoses, or in
doubt, a blood alcohol concentration of 54 mmol/L
(250 mg/dL) was used as the cutoff.
Of the 912 individuals studied, 460 (50%) were males
and the median age was 36 years (range 16–93), 37 in
males and 34 in females. The 23 (2.1%) patients who
refused to participate did not differ from the studied
population in terms of age, gender, poisoning intention
or main agents.
Data collection
All physicians attending poisoned patients in the five
hospitals in Oslo participated in the data collection. All
evaluations were done by the treating physician who
completed a standardized form that included informa-
tion that satisfied all of the study objectives. Each hos-
pital had a coordinator (medical doctor) monitoring the
study. These coordinators manually cross-checked the
forms against the electronic patient lists to ensure that
all patients meeting the criteria were included. The elec-
tronic data journal was used as a supplement where vari-
ables were missing. Variables still missing were coded as
unknown and excluded from that particular analysis.
Data were manually entered into an SPSS spreadsheet
and systematically checked for errors by randomly cross-
checking 10% of the variables with the original forms,
showing 99.94% consistency.
Outcome measures
In patients exposed to more than one substance, the
main toxic agent was defined as the substance suspected
to be the most toxic in the amount assumed taken. This
was the treating physicians’ clinical evaluation, based on
the information available, such as statements from the
patient, companions, ambulance service, clinical obser-
vations and laboratory findings. Substances presumed to
be less toxic were registered as coagents. In six cases,
the main agent was unknown. The median time from
exposure to hospital admission was recorded for all
patients, based on the information available, except
where ethanol was the main toxic agent. This was due to
practical difficulties in defining the exact time when the
ethanol was ingested. Consciousness was measured at
the time of hospital admittance. Coma was defined as
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(GCS). Complications were classified according to stand-
ard definitions, as in the similar study from 2003 [3],
and registered in relation to the treatment given.
Hypothermia was defined as body temperature below
35°C (95°F), hypoglycemia as serum glucose level
<3.5 mmol/L (63 mg/dL). Respiratory depression was
defined as respiratory acidosis (pH< 7.3, pCO2> 7.0
kPa), hypoxia (pO2< 8.0 kPa) or clinical need for venti-
lation support. Hypotension was defined as systolic
blood pressure below 85 mmHg in two subsequent mea-
surements. Conduction disturbances were classified as
arrhythmia, but sinus tachycardia was not. Other com-
plications were defined according to general clinical cri-
teria. Each complication was evaluated by the physician
as either related or unrelated to the treatment given.
Where antidotes had been administered, the exact time
for each complication was noted in relation to the anti-
dotes given. Complications arising within one hour after
intravenous N-acetylcysteine (NAC) administration and
within 10 min after flumazenil or naloxone administra-
tion were considered treatment related. Treatment-
related complications included among others broncho-
spasm, hypotension, arrhythmia, convulsions and rashes
if not typical of that specific type of poisoning. More un-
specific symptoms, such as nausea, vomiting, dizziness,
coughing and headache, were not included in this term.
Note that neither NAC nor flumazenil was administered
in a prehospital setting. The NAC regimen was identical
in all hospitals. NAC was administered intravenously
according to the Rumack-Matthew normogram in three
doses over a period of 21 h [9].
The intention behind the act of poisoning was evalu-
ated by the treating physician. Poisonings with sub-
stances of abuse, including heroin and ethanol for
recreational purposes, were classified as accidental over-
doses with substances of abuse (AOSAs). Suicidal motiv-
ation in the act of poisoning was classified as either a
possible or definite suicide attempt. This distinction was
based on whether the patient considered the toxic agent
lethal and whether other measures had been taken to
ensure a lethal outcome. If the motive was ambivalent
(e.g., by seeking help shortly after ingestion), the poison-
ing was classified as a possible suicide attempt. Acci-
dents included both external causes of poisoning and
self-inflicted accidents (e.g., taking the wrong medica-
tion) where the agent had been taken for neither self-
harm nor intoxication purposes.Statistics
Pearson’s chi-square or Fisher’s exact test (cell values
<5) were used to compare frequencies. Age comparisons
were done using Mann–Whitney U-test.Univariate logistic regression was used to analyze the
association between complications and antidotes given.
Univariate and multivariate logistic regression were used
to identify factors associated with intensive care treat-
ment. All variables included in the multivariate model
were clinically relevant and had a p value <0.20 in the
univariate analysis. The assumptions underlying multi-
variate logistic regression analyses were checked and
found to be adequately fulfilled. Findings with p values
<0.05 were considered statistically significant. SPSS 16.0
(SPSS Inc., Chicago, IL) was used to perform the statis-
tical analyses.
Ethics
This study was approved by the Norwegian Regional
Ethics Committee and the National Data Inspectorate.
Studying intoxicated patients is difficult, including ac-
quiring written consent, because of the nature of their
behavior and physical condition. The study participants
were therefore informed about the aims of the study and
were given a written information leaflet with the name
and phone number of the study coordinator. They were
also given the right to refuse participation or to with-
draw consent at any time without reprisal. Thereafter,
their verbal consent was confirmed by the independent
interviewing physician in a specific question included in
the standardized interview form.
Results
During the study year, 1065 admissions were recorded in
912 individuals (Figure 1), contributing to 1954 hospital
days (median 1, range <1–48). Seventy-five percent were
discharged after less than 24 h, 11% stayed 24–72 h,
while 14% stayed more than 72 h. Of the 519 (49%)
patients treated in an ICU, only 78 (15%) stayed more
than 24 h. Factors associated with ICU treatment were
coma (odds ratio 6, CI 4–10), a suicidal intention (OR 2,
CI 1–3) and neuroleptics as the main agent (OR 2, CI
1–4) (Table 1). The presence of complications or coa-
gents was a nonsignificant factor. The time from expos-
ure to admission was recorded in 611 (70%) of the cases
where ethanol was not the main agent and the median
time was 3.0 h (interquartile range 1.5–5.0).
Few patients (n = 181, 17%) received no further treat-
ment other than observation (Table 2). Supportive treat-
ment was given to 747 patients (70%), antidote(s) to 407
(38%) and activated charcoal to 167 (16%). Gastric lavage
was performed in 93 (9%) cases, of which 75 were per-
formed within two hours of ingestion. Intubation was
performed in 40 (4%) and mechanical ventilation in 36
(3%) with a median length of three days (range <1–
18 days). Noninvasive mask ventilation was performed
in 33 (3%), of which 21 were performed during transport
by the ambulance service. Twelve patients underwent
Figure 1 Complications and outcomes in acutely poisoned adults admitted to Oslo hospitals during one year 2008–2009.
Table 1 Factors associated with admission to an intensive
care unit among patients with acute poisoning in Oslo
during one year 2008–2009: Results of multivariate
logistic regression analysis
Crude Adjusted
Total ICU OR 95% CI OR 95% CI
Main agents
Other agents1 277 119 (43) Ref
Ethanol 194 85 (44) 1.0 0.7–1.5 1.0 0.6–1.5
Opioids 114 66 (58) 1.8* 1.2–2.8 1.2 0.7–2.1
GHB 85 50 (59) 1.9* 1.2–3.1 0.9 0.5–1.7
BZD 159 77 (48) 1.2 0.8–1.8 0.9 0.6–1.4
Paracetamol 117 47 (40) 0.9 0.6–1.4 0.8 0.5–1.3
Neuroleptics 60 39 (65) 2.5* 1.4–4.4 2.1* 1.2–3.9
Antidepressants 59 36 (61) 2.1* 1.2–3.7 1.5 0.8–2.8
Coagent
No 593 320 (54) Ref
Yes 472 199 (42) 0.6* 0.5–0.8 0.8 0.6–1.0
GCS
Awake (15) 508 194 (38) Ref
Drowsy (8–14) 356 166 (47) 1.4* 1.1–1.9 1.3 1.0–1.8
Comatose (<8) 201 159 (79) 6.1* 4.2–9.0 6.0** 3.8–9.5
Complications
No 744 322 (43) Ref
Resp. depression 128 87 (68) 2.8* 1.9–4.1 1.4 0.9–2.2
Other complications 193 110 (57) 1.7* 1.3–2.4 1.4 1.0–1.9
Intention2
Accidents 170 60 (35) Ref
AOSA 399 191 (48) 1.7* 1.2–2.4 1.1 0.7–1.7
Suicide attempt 495 267 (54) 2.1** 1.5–3.1 1.8* 1.2–2.7
Total cases 1065 519 (49)
AOSA accidental overdose with substances of abuse, BZD benzodiazepines,
GCS Glasgow Coma Scale, GHB gamma-hydroxybutyric acid.
*Significant, p< 0.05; **significant, p< 0.001.
1Main agents was unknown in six cases.
2One patient with unknown intention and one with unknown GCS score were
excluded from this analysis.
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with respiratory arrest and pronounced bradycardia.
All resuscitated patients had return of spontaneous cir-
culation (ROSC). Of the six patients treated with
hemodialysis, this was done for elimination purposes in
three patients (one case of ethylene glycol and two cases
of lithium poisoning) and in the rest for acute renal fail-
ure. The sole indicator for forced alkaline diuresis was
rhabdomyolysis. Of the 15 patients treated with hyper-
baric oxygen (HBO), one was because of gangrene com-
plications; the others had severe CO poisoning.
Flumazenil was given to 207 (19%): 41% of the cases
with benzodiazepines as the main agent, 25% of the
patients with benzodiazepines as a coagent, and in 33%
of the cases with benzodiazepine-like substances as the
main agent. Naloxone was given in a prehospital setting,
or in the hospital, to 186 (17%): 69% of the cases with
opioids as the main agent and 37% of the cases with
opioids as a coagent. In 101 (54%) cases, naloxone ad-
ministration did not improve the level of consciousness,
thus weakening the suspicion of opioid poisoning. Flu-
mazenil was given in 86 (42%) cases without an effect on
consciousness, weakening the suspicion of benzodiaze-
pines and their derivatives as the main toxic agents.
Intravenous NAC was administered in 120 (11%) cases,
of whom 96 (80%) had paracetamol as the main agent. A
NAC dose regimen was registered in 82 (68%) of the
cases; one dose was given in 39%, two in 16% and a full
dosage regimen in 45%. NAC was primarily stopped
early because of low s-paracetamol levels. The use of
physostigmine (n = 8, 1%) was associated with an epi-
demic of scopolamine poisoning [8]. More than one
antidote was given to 116 (11%) patients.
Of the 884 patients receiving treatment, 21 (2.4%)
developed complications classified as treatment related
(Table 3). Six patients experienced complications after
intravenous NAC administration. Five patients (5/120,
4.2%) experienced an urticarial rash and another devel-
oped severe bronchospasm (1/120, 0.8%), causing dis-
continuation of the NAC regimen. Seven patients
developed convulsions related to naloxone and/or fluma-
zenil administration. In total, 36 (3.4%) patients had
Table 2 Treatment for the most common main toxic agents causing acute poisonings in Oslo during one year
2008–2009
Ethanol Opioids GHB BZD Paracetamol1 Other Total
Treatment n % n % n % n % n % n % n %
Observation only 41 (21) 10 (9) 16 (19) 30 (19) 7 (6) 77 (19) 181 (17)
Treatment* 153 (79) 104 (91) 69 (81) 129 (81) 110 (94) 319 (81) 884 (83)
Total 1942 (100) 114 (100) 85 (100) 159 (100) 117 (100) 396 (100) 1065 (100)
Antidote(s) 35 (18) 81 (71) 41 (48) 74 (47) 99 (85) 77 (19) 407 (38)
-Flumazenil 28 (14) 24 (21) 33 (39) 65 (41) 5 (4) 52 (13) 207 (19)
-Naloxone 18 (9) 79 (69) 38 (45) 26 (16) 7 (6) 18 (5) 186 (17)
-N-acetylcysteine 5 (3) 3 (3) 5 (3) 96 (82) 11 (3) 120 (11)
-Physostigmine 13 (1) 43 (3) 34 (1) 8 (1)
-Phytonadione 4 (1) 4 (<0.5)
-Hydroxocobalamin 2 (1) 2 (<0.5)
-Biperiden 2 (1) 2 (<0.5)
-Other 1 (1) 5 (1) 6 (1)
Other treatment 152 (78) 87 (76) 60 (71) 114 (72) 84 (72) 304 (77) 801 (75)
-Supportive 149 (77) 84 (74) 60 (71) 105 (66) 75 (64) 274 (69) 747 (70)
-Activated charcoal 3 (2) 6 (5) 24 (15) 36 (31) 98 (25) 167 (16)
-Gastric lavage 3 (2) 3 (3) 14 (9) 20 (17) 53 (13) 93 (9)
-Intubation 2 (1) 9 (8) 5 (6) 3 (2) 2 (2) 19 (5) 405 (4)
-Mech. ventilation 2 (1) 9 (8) 4 (5) 3 (2) 1 (1) 176 (4) 36 (3)
-HBO 17 (1) 14 (4) 15 (1)
-Resuscitation 18 (1) 6 (6) 18 (1) 2 (1) 2 (1) 129 (1)
-Therapeutic hypothermia 6 (6) 1 (1) 2 (1) 2 (1) 11 (1)
-Forced alk. diuresis 1 (1) 3 (3) 3 (1) 7 (1)
-Hemodialysis 1 (1) 1 (1) 4 (1) 6 (1)
Alk alkalic, BZD benzodiazepines, GHB gamma-hydroxybutyric acid, HBO hyperbaric oxygen, Mech mechanical, Paracet paracetamol.
Supportive treatment consists of iv fluid, warming, nonantidote medication, and supportive care.
Antidotes given on only one occasion are listed as other.
*Including antidote(s) and supportive treatment.
1 Including paracetamol–codeine combination drugs.
2 61 (31%) patients had taken coagents.
3 Scopolamine coagent, or suspected scopolamine poisoning, but not verified according to criteria.
4 Scopolamine poisoning.
5 Four patients were intubated to secure airways during gastric decontamination.
6 Four cases of antidepressants, three of CO/fire smoke, three of neuroleptics, two of insulin, two of lamotrigine, one amlodipine, one amphetamine, and one case
of cocaine poisoning.
7 Gangrene.
8 Respiratory arrest only and severe bradycardia.
9 Of which two had respiratory arrest. All had return of spontaneous circulation.
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mazenil nor naloxone, 2/96 (2.1%) of those receiving flu-
mazenil alone, 1/74 (1.4%) of those receiving naloxone
alone and 4/109 (3.7%) of those receiving both. Four
patients experiencing convulsions prior to antidote ad-
ministration were excluded from this comparison. Pear-
son’s chi square test did not reveal any significant
difference in the rate of convulsions between any of
these groups. Two cases with aspiration pneumonia
were classified as treatment related after gastric lavage
(nonintubated patients). However, the rate was lower
than in those not lavaged.On presentation, 508 (48%) were awake, 356 (33%)
were drowsy and 201 (19%) were comatose. GHB was
the agent that most often caused coma (26%, 52/201),
followed by ethanol (20%, 40/201) and opioids (17%, 35/
201) (Table 4). Coma was most common in poisoning
with GHB (61%, 52/85), cocaine (38%, 5/13) and opioids
(31%, 35/114). Only 14% of women presented in a coma,
whereas 23% of males were comatose (p< 0.001).
Complications developed in 322 patients (30%): one in
208 (20%), two in 74 (7%) and three or more in 40
patients (4%) (Table 5). In 282 (26%) cases, the compli-
cations were already present on admission. The most
Table 3 Treatment-related complications in 21 out of 884
admissions in Oslo during one year 2008–2009
Treatment Complication n % of treated
N-acetylcysteine 5%
n= 120 Urticaria 5
Bronchospasm 1
Flumazenil and naloxone 4%
n= 1091 Convulsions 4
Naloxone 3%
n= 741 Convulsions 1
Allergic reaction 1
Flumazenil 2%
n= 961 Convulsions 2
Gastric decontamination 2%








1 Four patients with convulsions prior to flumazenil and/or naloxone
administration were excluded.
2 Treatment of convulsions.
3 Antibiotics and diazepam were not routinely registered.
4 Treatment of complications.
Table 4 Toxic agents causing coma and the most
common toxic agents in 201 comatose patients with
acute poisoning in Oslo during one year 2008–2009
Main agent % in a coma n (%) of coma
GHB (61) 52 (26)
Ethanol (21) 40 (20)
Opioids (31) 35 (17)
BZD (18) 28 (14)
Cocaine (38) 5 (2)
Antidepressants (8) 5 (2)
BZD-like substances (9) 5 (2)
Neuroleptics (8) 5 (2)
Paracetamol (4) 5 (2)
Others (10) 21 (10)
Total 201 (100)
BZD benzodiazepines, GHB gamma-hydroxybutyric acid.
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(n = 129, 12%), prolonged QTc interval (n = 64, 6%),
hypotension (n = 50, 5%) and pneumonia (n = 43, 4%).
Ten (1%) patients had a cardiac arrest with ROSC, of
which four died and three developed permanent brain
damage. In total, eight (0.8%) patients developed signs of
cerebral damage. The frequency of complications was
highest for opioids (56%), tricyclic antidepressants (54%)
and cardiovascular drugs (50%), while the mean number
of complications per admission was highest for tricyclic
antidepressants (mean 1.3).
Of the eight patients (0.8%) who died, three died
within 24 h of admission (Table 6). In three of these
patients, intensive care treatment was discontinued be-
cause of futility/severe anoxic brain damage. The mortal-
ity among those presenting in a coma and those
requiring mechanical ventilation was 4.0% (8/201, p
< 0.001) and 22.2% (8/36, p< 0.001), respectively. Five
(0.5%) patients survived with permanent sequelae. All
were male and the median age was 39 (range 23–48).
Four suffered anoxic brain damage following cardiac ar-
rest, while one patient developed mitral valve endocardi-
tis requiring surgery after an overdose with intravenous
(contaminated) heroin (Table 7).Discussion
Although 75% of the patients were discharged after only
one day, as many as 49% were observed in an ICU.
Nineteen percent presented in a coma, most frequently
caused by GHB or ethanol. Thirty percent developed
complications, compared with only 18% in 2003, and the
rate was highest for opioids and tricyclic antidepressants.
Seventy-five percent received treatment other than ob-
servation. Intravenous NAC was the only antidote asso-
ciated with treatment-related complications, and most
were mild. Five (0.5%) developed permanent sequelae, of
which three had anoxic brain damage. The inhospital
mortality rate was 0.8% and corresponds to similar stud-
ies [3,5].
Treatment
The proportion of patients receiving active treatment
and antidotes was similar to the 2003 study [3]. The pro-
portion receiving naloxone increased slightly from 2003
(14% vs. 17% in 2008, p = 0.03) reflecting an increase in
opioid poisonings (7% vs. 11% in 2008) (Lund C, Teige B,
Drottning P, Stiksrud B, Rui TO, Lyngra M, Ekeberg O,
Jacobsen D, Hovda KE: A one-year observational study of
all hospitalized and fatal acute poisonings in Oslo: Epi-
demiology, intention and follow-up, submitted). The pro-
portion receiving flumazenil declined slightly (23% vs.
19% in 2008, p = 0.04), although the fraction of poison-
ings by benzodiazepines was unchanged. Interestingly,
the proportion of patients receiving flumazenil diagnos-
tically increased from 23% to 42%, although the total use
declined. Thus, patients who were not benzodiazepine
intoxicated were more likely to receive flumazenil than
before, whereas those who had taken benzodiazepines
were less likely to be treated with the antidote, probably
because those patients were circulatory and respiratory















Others Total % of
total
poisonings 114 13 18 25 13 85 60 46 160 194 58 48 116 115 1065
with complications 64 7 9 12 6 35 17 13 41 48 14 8 16 32 322




1.1 1.3 0.9 0.8 0.8 0.6 0.5 0.4 0.4 0.3 0.4 0.2 0.2 0.4 0.5
observed in ICU 58 85 17 36 54 59 66 54 48 44 56 35 41 43 49
espiratory
epression
41 3 2 4 4 16 3 2 20 13 9 5 2 5 129 12
rolonged QTc 9 3 1 7 8 5 8 10 2 2 9 64 6
ypotension 9 1 2 2 4 3 5 12 4 3 5 50 5
neumonia 12 1 1 1 1 2 3 2 4 5 4 2 1 4 43 4
onvulsions 7 2 1 3 1 3 5 5 1 4 1 3 36 3
rrhythmia 6 2 6 1 9 1 2 1 3 4 35 3
ypothermia 6 1 2 6 1 5 10 2 1 34 3
habdomyolysis 8 1 1 1 3 2 1 1 18 2
cute renal failure 6 1 2 2 1 1 1 2 1 17 2
ardiac arrest ROSC 6 1 2 13 104 1
llergic reaction 1 1 1 2 65 11 1
rolonged QRS 1 3 1 2 2 9 1
erebral damage 3 1 1 1 1 16 87 1
ypoglycemia 2 3 2 7 1
thers 7 2 3 1 4 2 4 3 2 4 5 37 3
ZD benzodiazepines, GHB gamma-hydroxybutyric acid, ICU intensive care unit, ROSC return of spontaneous circulation, TCA tricyclic antidepressants.
Including a paracetamol–codeine combination drug.
77% among methadone.
After inhalation of propane and Freon gas in a car.
Of which four died and three developed permanent cerebral sequelae.
Allergic reaction to intravenous N-acetylcysteine administration.
Suicide attempt with insulin.






















































Table 6 Fatal acute poisonings in Oslo during one year 2008–2009
Sex, age Main agent Coagents Intention Days Days on ventilator Comments
♂ 25* Heroin Ethanol AOSA 6 6 CA (A) with ROSC. Anoxic brain damage.
♀ 25 Heroin AOSA 4 4 CA (A) with ROSC. Anoxic brain damage.
♀ 29 Insulin Ethanol Definite suicide 9 9 Hypoglycemic brain damage. Organ donor.
♀ 38 Methadone Heroin, BZD Possible suicide <1 <1 CA (A) with ROSC, long time anoxia.
♂ 45 Heroin Ethanol AOSA <1 <1 CA (A) with ROSC, circulatory failure.
♀ 75* BZD Accident, dementia 33 17 Coma, hypotension, respiratory failure.
♀ 77 Amlodipine BZD-like substances Definite suicide 1 1 Coma, acute renal failure, IABP, circulatory failure.
♀ 86* CO Definite suicide <1 <1 Coma, third-degree burn (25% of skin), HbCO
26%, respiratory failure.
*Active treatment discontinued.
AOSA accidental overdose with substances of abuse, A asystolia, BZD benzodiazepines, CA cardiac arrest, HbCO carboxyhemoglobin fraction, IABP intra-aortic
balloon pump, ROSC return of spontaneous circulation.
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http://www.sjtrem.com/content/20/1/49stable and had a better defined diagnosis. The liberal
diagnostic use of flumazenil was addressed after the 2003
study, but obviously with little effect.
Although still high, the rate of gastric lavage was al-
most halved compared with the 2003 study (17% vs. 9%
in 2008) [3]. In comparison, studies from the Nether-
lands and the UK showed lavage rates of 2% and zero
[10,11], reflecting local differences in treatment policies,
and indicating overuse of this procedure in Oslo.
According to international guidelines, there is no evi-
dence for gastric decontamination more than 1–2 h after
intake, except for intake of very toxic agents, or agents
with anticholinergic effects delaying gastric emptying
[12,13]. As such, it is surprising that one-fifth of these
procedures were performed after this time frame. In our
opinion, there is clinical evidence for gastric decontam-
ination in the most severely poisoned patients (based on
a clinical evaluation of complications and overall clinical
condition), also with a larger time window between ap-
parent time of ingestion and hospitalization, and such
practice is often associated with tablet content removed
from the stomach. A probable explanation for this may
be delayed gastric emptying, well known to be associated
with heavy ethanol intake [14]. We have only foundTable 7 Acute poisonings resulting in permanent sequelae in
Sex, age Main agent Coagents Intention Days Days o
♂ 23 GHB AOSA 9
♂ 25 Methadone Definite suicide
attempt
18
♂ 27 Heroin Definite suicide
attempt
14
♂ 44 Cocaine BZD, anabolic
steroids, paracetamol
AOSA 7
♂ 48 Heroin AOSA 17
A asystolia, AOSA accidental overdose with substances of abuse, BZD benzodiazepin
fibrillation.indirect support for this in the literature, as the most se-
verely poisoned patients are often excluded from studies
on gastric decontamination. As these patients accounted
for a small proportion in this study, the high use of gas-
tric decontamination should be assessed.
It may seem somewhat surprising that the majority of
ethanol poisonings received active treatment. However,
this consisted almost solely of supportive intravenous
fluids. Only 31% of these patients were exposed to mul-
tiple agents.
Treatment-related complications
The rate of treatment-related complications was low
(2.4%) and the only significant correlation was for intra-
venous NAC, which induced allergic reactions in 5% of
cases. Only one case of bronchospasm mandated treat-
ment termination, most probably related to the initial
bolus dose given over one hour. Intravenous NAC has
previously been correlated to allergic reactions at rates
of 3–6% [15,16], similar to the present study (5%).
Neither naloxone nor flumazenil, alone or in combin-
ation, could be linked to an increased rate of complica-
tions, such as convulsions, although this has been shown
in previous studies [6,17]. Although the diagnostic useOslo during one year 2008–2009
n ventilator Comments
CA (A). Pneumonia, generalized status
myoclonicus, cerebral edema. Severe cerebral damage.
7 Drug abuse. CA (A). Mild anoxic cerebral damage.
13 Drug abuse. Respiratory depression. Mild anoxic
cerebral damage.
3 CA (VF). Pneumonia, rhabdomyolysis and acute
renal failure. Mild cerebral damage.
Drug abuse. Pneumonia, acute renal failure and mitral
valve endocarditis requiring surgery. Prosthetic mitral valve.
es, CA cardiac arrest, GHB gamma-hydroxybutyric acid, VF ventricular
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http://www.sjtrem.com/content/20/1/49was liberal, it is likely that physicians did not administer
any antidotes under circumstances where they were con-
sidered contraindicated. The 2003 study showed an
increased rate of convulsions among patients receiving
flumazenil and naloxone in combination, but there was
no information about the onset of complications in rela-
tion to the time of antidote administration [3]. This
makes it difficult to determine whether the complica-
tions were caused by the antidotes given or if they were
merely correlated to the poisoning itself. Poisoning may
cause convulsions through respiratory depression and
hypoxia [18]. As an illustration, the four patients that
developed convulsions prior to antidote administration
were hypoxic. Consequently, hypoxia may seem to be
the main cause of convulsions in this study. A rando-
mized controlled trial of flumazenil versus a placebo
among comatose overdose patients showed no difference
in major complications, such as convulsions [7]. Al-
though seemingly safe, the cost-effectiveness of diagnos-
tic use has been questioned [19]. With no significant
side effects associated with its diagnostic (over)use, a
more restrictive use by doctors wanting a rapid diagnosis
in drowsy patients may be difficult to obtain. It has also
been argued that this liberal use of flumazenil may re-
duce the number of cerebral CT scans.
Complications
Less than half the patients were awake on admission, il-
lustrating the challenge in determining the main toxic
agent and hence the usefulness of knowing the current
pattern of poisoning in the area. GHB and ethanol were
the most common causes of coma on admission, as they
were in the 2003 study [3]. Opioids have now replaced
benzodiazepines as the third most common cause. The
comatose cocaine-poisoned subjects had also taken seda-
tives. The total proportion of patients presenting in a
coma was slightly lower compared with 2003 (23% vs.
19% in 2008, p = 0.02) [3].
Significantly more patients developed complications as
compared with 2003 (18% vs. 30% in 2008, p< 0.001)
[3]. This increase was mainly seen in terms of “heavy”
complications such as respiratory depression (largely
due to opioids), pneumonia, hypotension, hypothermia,
convulsions and renal failure. This indicates that the
present patient population was more severely poisoned
than that studied in 2003. Both the observed increase in
suicidal motivation and the increase in opioid poisoning
may support this (Lund C, Teige B, Drottning P, Stiksrud
B, Rui TO, Lyngra M, Ekeberg O, Jacobsen D, Hovda
KE: A one-year observational study of all hospitalized
and fatal acute poisonings in Oslo: Epidemiology,
intention and follow-up, submitted). A possible triage
confounder could be the large number (n = 2348) of low
acuity patients treated at the outpatient clinic in Oslo(the EMA), which more than doubled from 2003 to
2008 [20,21]. As such, the present hospitalized patients
may lack some of the “lighter” poisoned patients, as
reflected by the fact that those given observation only—
and no active treatment—decreased from 25% to 17%
[3]. Prehospital treatment of opioid overdoses is com-
mon in Oslo [21]; hence, assuming that the population
presenting in hospital is more severely poisoned or is
exposed to multiple agents seems logical.
Interestingly, half the patients were observed in an
ICU, although only 19% were comatose on admission. In
comparison, only 5% were observed in an ICU in a
Dutch study and the inhospital mortality was zero [10].
One reason for the extensive use is the triage pattern in
Oslo, with the majority of low acuity poisonings treated
at the EMA. However, the overall proportion treated in
an ICU (15%, 519/3413) was still three times as high as
reported in the Dutch study. This indicates overuse of
expensive resources. Presence of complications was not
associated with ICU treatment, in support of this. Never-
theless, the three predictors for ICU treatment, coma,
suicidal intention and intake of neuroleptics, seem rele-
vant from a patient safety perspective. Most of these
patients were only observed for a couple of hours in an
ICU until they were clarified/stabilized and could be re-
ferred to an observation unit. Even so, these patients
could probably be treated more cost-efficiently without
impacting patient safety.
Antidepressants, both selective serotonin reuptake
inhibitors and tricyclic (TCA), are known to cause QTc
prolongation in overdose [22]. As such, the observed in-
crease in prolonged QTc is interesting as the number of
poisonings with antidepressants was unchanged from
2003. One explanation could be the focus on prolonged
QTc as a marker for patients at special risk of develop-
ing “torsade de pointes” ventricular tachyarrhythmias.
The mean number of complications per admission was
highest for tricyclic antidepressants (mean 1.3), as in
2003 [3]. Although newer and “safer” antidepressants are
available, the proportion of both prescriptions and acute
poisonings with TCA has not declined since 2003
[2,23,24]. This may reflect that severe depressions are
still treated with TCA and these patients are the most
likely to attempt suicide.
Mortality and sequelae
Although one-third of the patients experienced compli-
cations, the mortality was relatively low and few devel-
oped sequelae. The inhospital mortality in Oslo was
0.8%, compared with 1.1% in 2003 and 0.5% in 1980
[3,5]. Both the mortality rate and rate of sequelae are
therefore at about the same level as in similar previous
studies from Oslo and from other countries [25,26].
However, the increasing number of poisonings treated at
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mortality actually is lower. Note that all patients dying
from cardiac arrest had asystolia (Table 6), known to be
associated with a poorer prognosis than ventricular fib-
rillation [27]. Also note that the only young patient who
died, who was not a drug abuser, became an organ
donor. The main cause of sequelae was substance abuse
poisonings in males, mainly by opioids. Methadone poi-
soning caused one drug-related death, and permanent
sequelae in a suicide attempt. This may reflect increasing
rates of methadone-related deaths in the Nordic coun-
tries in recent years [28,29]. Although increasing fatal-
ities, the number of participants in methadone
maintenance treatments in Oslo is increasing (n = 1171
in 2009), hence resulting in a relatively low mortality
rate [30]. Of all deaths from opioids in Oslo in 2008,
13% (9/72) were due to methadone (Lund C, Teige B,
Drottning P, Stiksrud B, Rui TO, Lyngra M, Ekeberg O,
Jacobsen D, Hovda KE: A one-year observational study
of all hospitalized and fatal acute poisonings in Oslo:
Epidemiology, intention and follow-up, submitted).Strengths and limitations
A major strength of this study is that it was conducted
prospectively within a defined geographical area. It
included unselected data of all acute poisonings
throughout a whole year, eliminating bias from seasonal
variations. Since similar studies were performed in the
same area in 1980 and 2003, comparisons are more reli-
able than comparing retrospective studies from differ-
ent—and often undefined—locations and populations.
In terms of limitations, many physicians assisted in the
inclusion of patients. This was an advantage when ensur-
ing complete inclusion, but it may have resulted in high
interrater variability. A few patients may also have been
missed, despite consecutive inclusion, cross-checking of
forms against hospital patient lists, and thorough follow-
ups.
It is debatable whether a routine verification of the
main toxic agents should have been performed to link
the complications to the right toxic agents. Moreover,
the presence of other agents may have affected these
correlations. However, as treatment is mainly symptom-
atic and not based on laboratory detection of toxic
agents, this study was mainly based on the clinical find-
ings and blood/urine tests used in a routine clinical set-
ting. Furthermore, the limited value of laboratory testing
in the clinical setting has been demonstrated [31]. The
evaluation of treatment-related complications was lim-
ited by a small sample size. All available information was
used to estimate the time from exposure to hospital ad-
mission, as this information would otherwise be difficult
to evaluate.Conclusions
The frequency of complications had almost doubled in
five years, although the poisoning pattern was largely
unchanged. The rate of complications was highest for
tricyclic antidepressants, opioids and cardiovascular
drugs. However, the inhospital mortality was low and
few developed permanent sequelae. The most common
cause of coma was GHB, ethanol and opioids. The use
of an ICU was liberal considering only one out of five
patients presented in a coma. Flumazenil and naloxone
were frequently given diagnostically and were not corre-
lated to any complications. Although NAC induced al-
lergic reactions, most were mild and did not require
treatment discontinuation.
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